Evaluation of sunobinop for next-day residual effects in healthy participants

• Main Authors: Alessandra Cipriano (Author), Ram P. Kapil (Author), Mingyan Zhou (Author), Manjunath S. Shet (Author), Stephen C. Harris (Author), Glen Apseloff (Author), Garth T. Whiteside (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Sunobinop is a novel, potent, selective partial agonist at nociceptin/orphanin FQ peptide (NOP) receptors. The primary objective of this randomized, double-blind, placebo-controlled study was to assess the next-day residual effects of an evening dose of sunobinop in healthy participants. Participant...